These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 6318671)

  • 1. Chemotaxis: basic aspects of methodology, mechanisms and pathology.
    Czarnetzki BM; Kownatzki E; Dierich M; Frei PC
    Arch Dermatol Res; 1983; 275(6):359-64. PubMed ID: 6318671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotaxin receptors on human neutrophils: modulation of C5a and peptide receptor number.
    Nelson RD; Chenoweth DE; Solomkin JS; Solem LD
    Agents Actions Suppl; 1983; 12():274-89. PubMed ID: 6301231
    [No Abstract]   [Full Text] [Related]  

  • 3. Neutrophil-endothelial cell interactions. Modulation of neutrophil adhesiveness induced by complement fragments C5a and C5a des arg and formyl-methionyl-leucyl-phenylalanine in vitro.
    Tonnesen MG; Smedly LA; Henson PM
    J Clin Invest; 1984 Nov; 74(5):1581-92. PubMed ID: 6501563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotactic peptides modulate adherence of human polymorphonuclear leukocytes to monolayers of cultured endothelial cells.
    Charo IF; Yuen C; Perez HD; Goldstein IM
    J Immunol; 1986 May; 136(9):3412-9. PubMed ID: 3514759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the plasma membrane bound GTPase from rabbit neutrophils. I. Evidence for an Ni-like protein coupled to the formyl peptide, C5a, and leukotriene B4 chemotaxis receptors.
    Feltner DE; Smith RH; Marasco WA
    J Immunol; 1986 Sep; 137(6):1961-70. PubMed ID: 3018082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil dysfunction in sepsis. II. Evidence for the role of complement activation products in cellular deactivation.
    Solomkin JS; Jenkins MK; Nelson RD; Chenoweth D; Simmons RL
    Surgery; 1981 Aug; 90(2):319-27. PubMed ID: 7256544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipopolysaccharide modulates receptors for leukotriene B4, C5a, and formyl-methionyl-leucyl-phenylalanine on rabbit polymorphonuclear leukocytes.
    Goldman DW; Enkel H; Gifford LA; Chenoweth DE; Rosenbaum JT
    J Immunol; 1986 Sep; 137(6):1971-6. PubMed ID: 3018083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of human neutrophil chemotaxis by the protein kinase inhibitor, 1-(5-isoquinolinesulfonyl) piperazine.
    Harvath L; McCall CE; Bass DA; McPhail LC
    J Immunol; 1987 Nov; 139(9):3055-61. PubMed ID: 2822802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphonuclear leukocytes cap a derivative of wheat germ agglutinin upon stimulation with formyl peptide and C5a but not leukotriene B4.
    Kurrasch R; Elfman F; Perez HD
    J Immunol; 1989 Sep; 143(6):1969-73. PubMed ID: 2550548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deactivation of guinea pig pulmonary alveolar macrophage responses to N-formyl-methionyl-leucyl-phenylalanine: chemotaxis, superoxide generation, and binding.
    Daughaday CC; Mehta J; Spilberg I; Atkinson JP
    J Immunol; 1985 Mar; 134(3):1823-6. PubMed ID: 2981922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotaxis of radiolabeled equine neutrophils.
    Camp CJ; Leid RW
    Am J Vet Res; 1982 Mar; 43(3):397-401. PubMed ID: 7073055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human neutrophil Fc gamma RIIIB and formyl peptide receptors are functionally linked during formyl-methionyl-leucyl-phenylalanine-induced chemotaxis.
    Kew RR; Grimaldi CM; Furie MB; Fleit HB
    J Immunol; 1992 Aug; 149(3):989-97. PubMed ID: 1321856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical significance and study of granulocyte function].
    Helbig W; Jaworkowsky L; Storch H
    Z Gesamte Inn Med; 1980 Feb; 35(3):101-7. PubMed ID: 6994379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotaxis and motility of lung phagocytes.
    Nelson RD; Herron MJ
    Semin Respir Infect; 1986 Jun; 1(2):79-88. PubMed ID: 3317605
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulation of monocyte function by complement activation products.
    Antrum RM; Solomkin JS
    J Surg Res; 1985 May; 38(5):468-74. PubMed ID: 3990275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human granulocytes and granulocytes from other species demonstrate differences in chemotactic responsiveness to oxidized N-formyl-methionyl-leucyl-phenylalanine.
    Harvath L; Aksamit RR
    Comp Biochem Physiol A Comp Physiol; 1989; 92(1):97-100. PubMed ID: 2567657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Independent regulation of human neutrophil chemotactic receptors after activation.
    Bender JG; Van Epps DE; Chenoweth DE
    J Immunol; 1987 Nov; 139(9):3028-33. PubMed ID: 2822801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotactic peptide from ropalidian wasp as well as the authentic chemotactic tripeptide stimulates two distinct pathways in neutrophils, but the [LYS7] analog does only one of them.
    Koike M; Nagashima K; Saito K; Nakanishi M; Fujino M; Nakajima T
    Biochem Biophys Res Commun; 1991 Feb; 175(1):165-72. PubMed ID: 1847803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human monocyte adherence: a primary effect of chemotactic factors on the monocyte to stimulate adherence to human endothelium.
    Doherty DE; Haslett C; Tonnesen MG; Henson PM
    J Immunol; 1987 Mar; 138(6):1762-71. PubMed ID: 3819394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of inflammation and leukocyte chemotaxis in the rheumatic diseases.
    Snyderman R
    Med Clin North Am; 1986 Mar; 70(2):217-35. PubMed ID: 3005783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.